Mail

UK markets closed

FTSE 100
8,139.83
+60.97(+0.75%)
FTSE 250
19,824.16
+222.18(+1.13%)
AIM
755.28
+2.16(+0.29%)
GBP/EUR
1.1681
+0.0024(+0.21%)
GBP/USD
1.2498
-0.0013(-0.11%)
Bitcoin GBP
51,168.02
-650.12(-1.25%)

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Laboratorios Farmaceuticos Rovi, S.A. (LABFF)

Other OTC - Other OTC Delayed price. Currency in USD

Add to watchlist

86.05

0.00

(0.00%)

As of 11:47AM EDT. Market open.

Currency in USD

Valuation measures⁴

Market cap (intra-day)	4.64B
Enterprise value	4.69B
Trailing P/E	25.12
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	5.16
Price/book (mrq)	7.64
Enterprise value/revenue	5.65
Enterprise value/EBITDA	19.10

Trading information

Stock price history

Beta (5Y monthly)	0.49
52-week change ³	68.40%
S&P500 52-week change ³	21.08%
52-week high ³	86.05
52-week low ³	50.88
50-day moving average ³	76.52
200-day moving average ³	58.24

Share statistics

Avg vol (3-month) ³	1
Avg vol (10-day) ³	N/A
Shares outstanding ⁵	51.25M
Implied shares outstanding ⁶	53.97M
Float ⁸	19.28M
% held by insiders ¹	60.25%
% held by institutions ¹	18.34%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	1.41
Forward annual dividend yield ⁴	1.64%
Trailing annual dividend rate ³	1.10
Trailing annual dividend yield ³	1.28%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	40.43%
Dividend date ³	N/A
Ex-dividend date ⁴	03 Jul 2023
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	20.53%
Operating margin (ttm)	28.23%

Management effectiveness

Return on assets (ttm)	16.34%
Return on equity (ttm)	31.98%

Income statement

Revenue (ttm)	829.51M
Revenue per share (ttm)	15.34
Quarterly revenue growth (yoy)	-3.10%
Gross profit (ttm)	N/A
EBITDA	243.8M
Net income avi to common (ttm)	170.34M
Diluted EPS (ttm)	3.42
Quarterly earnings growth (yoy)	-34.10%

Balance sheet

Total cash (mrq)	25.32M
Total cash per share (mrq)	0.49
Total debt (mrq)	65.43M
Total debt/equity (mrq)	12.04%
Current ratio (mrq)	2.55
Book value per share (mrq)	10.41

Cash flow statement

Operating cash flow (ttm)	113.25M
Levered free cash flow (ttm)	25.34M